Abbott Laboratories (ABT) Stock Price, Quote, News & History | Benzinga

Abbott Laboratories (ABT) Stock Price, Quote, News & History

ABTNYSE

Trade with Public

Trade with Public

$114.14

-0.29-0.25%

At close: Aug 20, 5:00 PM EST

$114.00

-0.14-0.12%

After Hours: 6:28 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Dividends Compare Options Stock Report

Key Statistics

Open

$114.00

Close

$114.14

Volume / Avg.

5.79M / 11.94M

Day Range

$113.99 - $115.23

52 Wk Range

81.97 - 137.49

Market Cap

$197.26B

P/E Ratio

37.03

Dividend Yield

2.20%

Exchange

NYSE

RSI

74

Short Interest

1.46%

Days to Cover

1.66

Recent Abbott Laboratories News

Congressman Ditches Blue Chip Stocks for Municipal Bonds: Here Are the Sales

A congressman reported selling stocks recently, while also investing in a municipal bond.

Chris Katje

These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results

Abbott Laboratories (NYSE:ABT) reported strong Q2 results, raising its full-year earnings outlook. Analysts have a positive outlook on ABT stock.

Avi Kapoor

Abbott To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Friday

Recent analyst rating changes, top names such as PPG, SAH, ISRG, MMM, OKE, GLDG, ABT, NFLX, TSCO, and SBAC were upgraded or downgraded.

Avi Kapoor

Why Is Intuitive Surgical Stock Sinking Friday?

ISRG stock drops 11% as Intuitive Surgical beats Q2 estimates but warns insurance changes could slow U.S. procedure growth.

Lekha Gupta

Nasdaq Tumbles 1.5% Amid Selloff In Chip Stocks: Investor Sentiment Weakens, Greed Index Moves To ‘Fear’ Zone

Market sentiment declined as stocks fell, with tech stocks leading the way. UnitedHealth Group and Abbott Laboratories reported strong earnings.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

9.90B

Investing Cash Flow (TTM)

-22.37B

Financing Cash Flow (TTM)

10.64B

Free Cash Flow (TTM)

7.82B

Capital Expenditure (TTM)

-2.08B

Net Change in Cash (TTM)

-1.82B

Analyst Trends and Forecast

2

Mar

13

Apr

1

Jun

11

Jul

1

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$225.01B

PE Ratio (TTM)

37.03

PE Ratio (FWD)

20.75

PEG Ratio (TTM)

2.30

PS Ratio (TTM)

4.29

PB Ratio (TTM)

3.87

Earnings Yield % (TTM)

2.70%

Earnings Yield % (FWD)

4.82%

EV / EBITDA (TTM)

19.19

Price / EBITDA (TTM)

17.04

Price / Free Cash Flow (TTM)

25.54

Book Value / Share

$29.54

Company Debt

Total Debt

$32.61B

LT Debt

$29.60B

LT Debt Issuance (TTM)

$19.83B

LT Debt Repayment (TTM)

-$3.32B

Total Cash

$5.10B

Debt to Equity

0.64

Issuance of Debt (TTM)

$16.51B

Repayment of Debt (TTM)

-$3.32B

Key Statistics

Open

$114.00

Close

$114.14

Volume / Avg.

5.79M / 11.94M

Day Range

$113.99 - $115.23

52 Wk Range

81.97 - 137.49

Market Cap

$197.26B

P/E Ratio

37.03

Dividend Yield

2.20%

Exchange

NYSE

RSI

74

Short Interest

1.46%

Days to Cover

1.66

About

Sector

Health Care

Industry

Health Care Equipment & Supplies

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neu...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Abbott Laboratories (ABT) stock?

A

You can purchase shares of Abbott Laboratories (NYSE:ABT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Abbott Laboratories (ABT) competitors?

A

Other companies in Abbott Laboratories’s space includes: Stryker Corp (NYSE:SYK), Medtronic PLC (NYSE:MDT), Boston Scientific Corp (NYSE:BSX), Becton Dickinson & Co (NYSE:BDX) and Edwards Lifesciences Corp (NYSE:EW).

Q

What is the forecast, or price target, for Abbott Laboratories (ABT) stock?

A

Abbott Laboratories has a consensus price target of $128.56.

Q

What is the current price for Abbott Laboratories (ABT)?

A

The stock price for Abbott Laboratories (NYSE: ABT) is $114 last updated August 20, 2026 at 6:28 PM EDT.

Q

Does Abbott Laboratories (ABT) pay a dividend?

A

There are no upcoming dividends for Abbott Laboratories.

Q

When is Abbott Laboratories (NYSE:ABT) reporting earnings?

A

Abbott Laboratories does not have any upcoming earnings scheduled.

Q

Is Abbott Laboratories (ABT) going to split?

A

There is no upcoming split for Abbott Laboratories.

Q

What sector and industry does Abbott Laboratories (ABT) operate in?

A

Abbott Laboratories is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.